A little over a year after taking over the CEO role at Ambu A/S, Britt Meelby Jensen visits the DeviceTalks Weekly Podcast to draw lessons from her career that led her to lead the single-use endoscope leader last year. At the time, Meelby Jensen says Ambu was missing Wall Street expectations. In this interview, Jensen highlights the benefits of single-use endoscopes, such as improved workflow and reduced waiting times, and emphasizes Ambu's focus on sustainability. She’ll also review the company’s plan to retain its position in the white-hot single-use scope industry. But first Host Tom Salemi take a dive into earnings week with MassDevice Executive Editor Chris Newmarker and Associate Editor Sean Whooley. We won’t dig too deep into the numbers, but instead we’ll ask why Wall Street investors don’t seem too impressed with the performance of some high-flying medical device companies.

Join us at DeviceTalks West on Oct. 18-19 for some in-person discussions!

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Ver todos los episodios